戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  carriers may have an increased incidence of premature menopause.
2 ), postmenopausal hormone therapy (11%), and premature menopause (1%).
3 at menopause 43.7 +/- 8.6 years), women with premature menopause (29.3%) were younger at enrollment (
4 MD include age, previous fragility fracture, premature menopause, a family history of hip fracture, a
5                          The associations of premature menopause (age at menopause of <40 years) and
6                             Counseling about premature menopause and fertility changes is an overlook
7 adiotherapy, and radical surgery, can induce premature menopause and infertility in hundreds of thous
8 e women at risk for acute ovarian failure or premature menopause and men at risk for temporary or per
9 motherapy, adjuvant; menstruation disorders; premature menopause, and amenorrhea.
10 oses were at risk for acute ovarian failure, premature menopause, and small-for-gestational-age offsp
11 ramifications involved with the induction of premature menopause as well as potential benefits necess
12 enopause (at age < 47 years), 33 of whom had premature menopause (at age < 40 years), as well as amon
13 ay more limited features of aging, including premature menopause; both syndromes involve genome insta
14 he chronic effects of cancer (pain, fatigue, premature menopause, depression/anxiety), monitoring for
15 opause and a > or = 9-fold increased risk of premature menopause due to an FMR1 premutation, under a
16 ewed the frequency of acute ovarian failure, premature menopause, live birth, stillbirth, spontaneous
17 f PM and PO is low, but the complications of premature menopause may be significant, and few studies
18                                     Although premature menopause may occur in a small proportion of p
19 early menopause and suggest that the risk of premature menopause to fragile X-premutation carriers ma
20  a > or = 26-fold increased risk of familial premature menopause, under a less probable model in whic
21 opause at age 40 or more years compared with premature menopause was associated with a 50% decreased
22 resistance, and hormone replacement therapy, premature menopause was associated with an increased lik
23 surface area (which has been associated with premature menopause) was associated with a significantly

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。